Treatment

October 24, 2017

EUPATI, European Patients’ Academy on Therapeutic Innovation, is a patient-led initiative that uses training courses, educational material and an online public library for empowering patients to engage more effectively in the development and approval of new treatments and become true partners in pharmaceutical research and development. Filippo Buccella, chairman of the Italian Liaison Team explains to ASSET how this initiative can involve healthy citizens as well, improving preparedness to infectious outbreaks and other crises.

Monday, October 30, 2017 - 11:00

ASSET is close to its conclusion and a concluding conference will be held in Rome, on October 30-31, to present all the main outcomes of the project. This event will take place at the hotel NH Roma Leonardo Da Vinci and will be targeted to a selected audience of EU stakeholders and policy makers. Its aim is to enhance advocacy and intersectoral approach in a multisetting scenario applied to fostering preparedness and response toward Public Health Emergency of International Concern (PHEIC), like epidemics and even pandemics.

ASSET is close to its conclusion and a concluding conference will be held in Rome, on October 30-31, to present all the main outcomes of the project. This event will take place at the hotel NH Roma Leonardo Da Vinci and will be targeted to a selected audience of EU stakeholders and policy makers. Its aim is to enhance advocacy and intersectoral approach in a multisetting scenario applied to fostering preparedness and response toward Public Health Emergency of International Concern (PHEIC), like epidemics and even pandemics.

Persons over the age of 65 have a higher risk for severe influenza-related complications and have the highest risk of mortality from influenza. Vaccination of older persons have traditionally been the main focus of influenza vaccine policy, and while vaccines are not as efficient in this population as in younger adults, it still remains the most effective public health tool to protect against influenza (WHO 2012). Vaccination recommendations vary slightly between countries in Europe, however almost all cover older people as a specific target group (Endrich et al 2009).

ASSET is close to its conclusion and a concluding conference will be held in Rome, on October 30-31, to present all the main outcomes of the project. This event will take place at the hotel NH Roma Leonardo Da Vinci and will be targeted to a selected audience of EU stakeholders and policy makers. It is conceived as a mobilization and mutual learning event at local, national and international levels on Science in Society related issues in epidemics and pandemics.

As reported in the ASSET Strategic plan, the three Summer Schools on Science in Society related issues in Pandemics (2015, 2016, 2017) pose the main challenge of the collaborative project overall that is dealing with the intersectoral approach required by the management of Public Health Emergencies of International Concern (PHEIC), like epidemics and pandemics.

Wednesday, April 26, 2017 (All day)

Members of the ASSET projects will present the results of the citizen consultation that took place in eight countries on September 2016 at the European Parliament. Such an event is part of the science-in-society approach performed by the project within the framework of Research and Innovation related to pandemic preparedness. ASSET citizen consultation is an innovative method of engaging citizens on complex issues, providing them with information before asking questions.

Drug Approval Regulation in Canada and USA

Since the thalidomide tragedy in the late1950s, there has been a reluctance to include women of childbearing age in clinical trials. However, this fear cannot be used as an excuse to not include females in clinical trials, and, with proper care and regulation, increased female participation has been reached. The United States adopted regulation early on to increase the participation of women, while a new regulation in Europe is going to improve this as well. Here follows an overview of the issue in Canada and in the USA. The third part of this series will deal with new regulation in Europe.

Attention to sex and gender in biomedical, health and clinical research is an important quality and safety issue. Medicinal products are safer and more effective for everyone when clinical research includes diverse population groups. Historically, women’s health issues have focused on reproductive health, followed by gender issues such as behaviour, socio-economic factors, culture, lifestyles and influence biological development and health.

Pages

Subscribe to Treatment

MMLAP and other EU Projects

Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
Making society an active participant in water adaptation to global change
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
Engaging all of Europe in shaping a desirable and sustainable future
Expect the unexpected and know how to respond
Driving innovation in crisis management for European resilience
Effective communication in outbreak management: development of an evidence-based tool for Europe
Solutions to improve CBRNe resilience
Network for Communicable Disease Control in Southern Europe and Mediterranean Countries
Developing the framework for an epidemic forecast infrastructure
Strengthening of the national surveillance system for communicable diseases
Surveillance of vaccine preventable hepatitis
European monitoring of excess mortality for public health action
European network for highly infectious disease
Dedicated surveillance network for surveillance and control of vaccine preventable diseases in the EU
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
Bridging the gap between science, stakeholders and policy makers
Promotion of immunization for health professionals in Europe
Towards inclusive research programming for sustainable food innovations
Addressing chronic diseases and healthy ageing across the life cycle
Medical ecosystem – personalized event-based surveillance
Studying the many and varied economic, social, legal and ethical aspects of the recent developments on the Internet, and their consequences for the individual and society at large
Get involved in the responsible marine research and innovation
Knowledge-based policy-making on issues involving science, technology and innovation, mainly based upon the practices in Parliamentary Technology Assessment
Assessment of the current pandemic preparedness and response tools, systems and practice at national, EU and global level in priority areas
Analysis of innovative public engagement tools and instruments for dynamic governance in the field of Science in Society
Public Engagement with Research And Research Engagement with Society
Computing Veracity – the Fourth Challenge of Big Data
Providing infrastructure, co-ordination and integration of existing clinical research networks on epidemics and pandemics
Promote vaccinations among migrant population in Europe
Creating mechanisms for effectively tackling the scientific and technology related challenges faced by society
Improve the quality of indoor air, keeping it free from radon
Improving respect of ethics principles and laws in research and innovation, in line with the evolution of technologies and societal concerns
Investigating how cities in the West securitise against global pandemics
Creating a structured dialogue and mutual learning with citizens and urban actors by setting up National Networks in 10 countries across Europe
Identifying how children can be change agents in the Science and Society relationship
Establishing an open dialogue between stakeholders concerning synthetic biology’s potential benefits and risks
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence